Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study.

Ali AljubranMahmoud A ElshenawyMagdy KandilMuhammed N ZahirAhmed ShaheenAhmed GadOmar AlshaerAhmed AlzahraniAbdelmonem EldaliShouki Bazarbashi

Published in: Clinical Medicine Insights. Oncology (2019)

Regorafenib in our clinical practice has equal efficacy to reported data from pivotal registration trials. Our data suggest that performance status is the most important prognostic factor in patients treated with regorafenib, suggesting a careful selection of patients.

Keyphrases

metastatic colorectal cancer
prognostic factors
clinical practice
end stage renal disease
electronic health record
newly diagnosed
ejection fraction
big data
peritoneal dialysis
machine learning